Search

Start typing to see results...

  • Home
  • >
  • Stock Market
  • >
  • Syncom Formulations India Ltd

Syncom Formulations India Ltd share price and stock overview

Syncom Formulations India Ltd (NSE: SYNCOMF, BSE: 524470) operates in the Pharmaceuticals - Indian - Bulk Drugs & Formln sector. The stock has an ISIN of INE312C01025 and a face value of Rs 1. As of 28 September 2026, it trades at Rs (22.06) with a market capitalisation of Rs 1885.64 crore. Figures are live and subject to change.

Syncom Formulations India Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln
NSE BSE
22.06 2.01 (10.02%) upARrowC
As on: 28-Sep-2026 , 11:34 AM
Market Cap(₹Cr) 1885.64
Book Value(₹Cr) 4.3862181
BSE Code : 524470 NSE Symbol : SYNCOMF EPS(TTM) : 0.9 ISIN Demat : INE312C01025 P/E(TTM) : 22.29 Face Value(₹) : 1 Div & Yield % : 0.5

Today Market

Stock Performance

Today Market

Today's High

73,740.85

Todday's Low

72,832.08

Open at

73,734.83

Previous Close

73,895.74

Volumes

0.00

Avg Price

-954.34

Historical Performance

News

26 Sep 26
Syncom Formulators' promoters forgo Rs 47.5 crore dividend payout for fiscal 2026
Syncom Formulations (India) Limited informed the Bombay Stock Exchange and National Stock Exchange that its Promoters and Promoter Group have voluntarily waived their entitlement to receive the final dividend of Rs 0.
24 Sep 26
Syncom Formulations closes share trading window ahead of financial results release
Syncom Formulations (India) Limited informed the Bombay Stock Exchange and National Stock Exchange that the trading window for its shares will be closed from October 1, 2026, until 48 hours after the declaration of the company’s unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, in compliance with SEBI regulations.
18 Sep 26
Syncom Formulations sets September 23, 2026, as record date for shareholder dividend
Syncom Formulations (India) Limited has fixed Wednesday, September 23, 2026, as the record date for determining the entitlement of members for a dividend of Rs 0.
11 Aug 26
Syncom Formulations announces management changes, including new directors and CFO, pending approval
Syncom Formulations (India) Limited announced changes to its board and senior management, effective August 11, 2026.

Historical Prices

Share Price Chart

Historical Share Price

From Date:
To Date:     
Date Open Price (₹) High Price(₹) Low Price(₹) Close Price(₹) Total Volume No of Trades Net Turnover(₹) NIFTY
25-09-26 20.13 20.40 19.61 20.05 7105116 12877 142138539.62 23140.50
24-09-26 20.01 20.75 19.80 20.03 12034163 25964 243252524.45 23063.10
23-09-26 20.57 20.67 19.80 20.01 5293142 9863 106669968.29 23446.80
22-09-26 19.87 21.00 19.87 20.40 9828587 16105 202861648.34 23329.00
21-09-26 20.04 20.50 19.62 19.85 6029044 12125 120873858.20 23414.30
18-09-26 18.80 20.25 18.80 20.04 10260532 18764 203644881.80 23346.40
17-09-26 18.40 19.05 18.16 18.78 5134471 9885 96004766.51 23270.60
16-09-26 18.56 18.88 16.61 18.41 10523823 22986 189038152.36 23217.60
15-09-26 19.69 19.85 18.44 18.53 5369736 11696 101575226.11 23118.60
11-09-26 18.98 20.10 18.51 19.46 9148018 18167 177053167.01 23398.10
123...

Fundamentals

Company Valuation

Market Cap (₹cr)

1885.64

PE Ratio

22.29

PB Ratio

4.57

Dividend Yield

0.5

ROE

20.21

ROCE

26.42

Book Value (₹)

4.3862181

Face Value (₹)

1

Share Holding Pattern

Category of Shareholder No of Shares % Share Holdings Demat Shares Share Holders
plus  Promoter & Group
plus  Foreign
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
plus  Indian
Bodies Corporate-Indian (Promoter & Group) 83061125 8.84 83061125 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 392286474 41.73 392286474 11
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 475347599 50.57 475347599 13
Total ShareHolding for Promoter & Group 475347599 50.57 475347599 13
plus   Publice Share Holding
plus  Institution
Government(Central / State) 7000 0.00 7000 1
Clearing Members 0 0.00 0 0
Corporate Bodies 4500 0.00 4500 1
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 3280678 0.35 3280678 15
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 18925 0.00 18925 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 3311103 0.35 3311103 19
plus  Non Institution
Bodies Corporate 9486453 1.01 9483953 199
Clearing Members 317562 0.03 317562 22
Directors & their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 17047220 1.81 16944720 2035
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 9959452 1.06 9959452 1744
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 61145776 6.50 61145776 141
Individuals holding nominal share capital up to Rs. 1 lakh 360906020 38.39 358589340 417919
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 2320331 0.25 2320331 1
Sub Total 461341298 49.08 458919618 422082
Total Public Shareholding 464652401 49.43 462230721 422101
Total of Promoter & Public ShareHolding 940000000 100.00 937578320 422114
plus  Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total 940000000 100.00 937578320 422114

Financials (₹ in cr)

Consolidated Standalone
Year EndMar 2026Mar 2025Mar 2024Mar 2023
Net Sales489.17465.01263.39224.25
OPM (%)20.6614.0912.9011.84
OP101.0865.5133.9826.56
Other Income31.3417.4313.5314.60
PBIDT108.8171.5743.1534.24
INTEREST1.160.864.473.13
PBDT107.6570.7138.6831.11
PBT101.1665.5233.9326.59
EO0.040.01-0.020.01
PBT after EO101.1265.5133.9526.57
TAXES24.6816.088.646.50
PAT76.4449.4325.3120.07
EPS0.810.530.340.24
Raw Material45.1759.7949.9444.35
Power and Fuel1.181.122.182.21
Employee Cost13.7111.2213.3111.53
Other Manufacturing Expenses0.260.240.451.02
Selling and Administration Expenses9.158.4011.5511.70
Miscellaneous Expenses1.160.901.241.20
Revenue (Growth %) 5.2076.5517.452.09
PBIDT (Growth %)52.0365.8726.016.84
PAT (Growth %) 54.6295.2826.131.42
PBIDT (Margin %)22.2415.3916.3815.27
PAT (Margin %) 15.6310.639.618.95

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Share Capital 94.0094.0094.0094.0086.2579.00
Reserves Total 318.30245.90192.45162.01130.9498.84
Equity Share Warrants0.000.000.000.005.049.75
Equity Application Money0.000.000.000.000.000.00
Total Shareholders Funds412.30339.90286.45256.01222.23187.59
Secured Loans 0.684.0471.6583.1857.7962.09
Unsecured Loans 0.020.000.000.000.000.00
Total Debt0.704.0471.6583.1857.7962.09
Other Liabilities6.995.505.024.233.192.93
Total Liabilities419.99349.44363.12343.42283.21252.61
APPLICATION OF FUNDS :
Gross Block 251.17192.96183.00149.26147.81142.31
Less : Accumulated Depreciation 67.6568.0563.2558.5354.0750.86
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 183.52124.91119.7590.7393.7491.45
Lease Adjustment0.000.000.000.000.000.00
Capital Work in Progress0.000.000.0025.596.200.38
Producing Properties0.000.000.000.000.000.00
Investments 109.0892.8666.2264.1343.3211.06
Current Assets, Loans & Advances
Inventories 62.8541.2921.0820.7719.5122.56
Sundry Debtors 107.60106.9493.2175.1467.5574.82
Cash and Bank Balance5.120.6967.838.580.3964.20
Loans and Advances 43.9529.3216.8114.0110.9618.37
Total Current Assets219.52178.24198.94118.5098.40179.95
Less : Current Liabilities and Provisions
Current Liabilities 94.9149.8119.9526.4816.6132.42
Provisions 6.234.123.452.613.852.19
Total Current Liabilities & Provisions101.1453.9323.4029.0920.4634.61
Net Current Assets118.38124.32175.5489.4177.94145.34
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets1.361.050.830.680.600.38
Deferred Tax Liability9.497.365.815.105.184.82
Net Deferred Tax-8.13-6.31-4.98-4.42-4.58-4.44
Other Assets17.1513.676.5977.9966.578.80
Total Assets419.99349.45363.12343.43283.19252.60
Contingent Liabilities0.780.860.550.550.550.55

Cash Flow (₹ in cr)

Yearly Cash FlowMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Financing Activities 8.2935.00-15.37-67.59-3.22
Investing Activities -27.07-44.9783.83-18.38-50.64
Net Cash Flow -2.450.5362.52-62.664.43
Operating Activities 16.3310.50-5.9423.3158.29

Peers

Balance Sheet Financial Ratios Profit & Loss
Aarti Pharmalabs...

930.60

(-0.95%)
Accent Microcell...

681.00

(+0.91%)
Accretion Pharma...

196.10

(-3.54%)
Achyut Healthcar...

Advanced Enzyme ...

284.90

(-2.15%)
Akums Drugs & Ph...

807.95

(-1.42%)
Albert David Ltd

863.90

(-1.13%)
Alembic Pharmace...

855.05

(-1.01%)

Corporate Actions

Bonus Dividends Splits
DateCorporate ActionInformation
No Corporate Actions Announced

Board of Directors

Chairman & Chief Executive Officer
AKB
ANKIT KEDARMAL BANKDA
Chairman / Executive Director / WTD
Executive
Functional Directors
RVB
Rahul Vijay Bankda
Managing Director &Addtnl Dir.
MD
RAB
Rinki Ankit Bankda
WTD & Additional Director
Dir.
Independent Directors
RJ
Ruchi Jindal
Independent Non Exe. Director
Ind.
RKL
Ritesh Kumar Lunkad
Independent Non Exe. Director
Ind.
AJ
Ankit Jain
Independent Non Exe. Director
Ind.
Other Officials
VA
Vaishali Agrawal
Company Sec. & Compli. Officer
Board

Frequently Asked Questions

What is the NSE symbol and BSE code for Syncom Formulations India Ltd? −

Syncom Formulations India Ltd trades on NSE under SYNCOMF and on BSE under code 524470. The ISIN is INE312C01025 and the face value is Rs 1.

What is the share price of Syncom Formulations India Ltd today? +

As of 28 September 2026, Syncom Formulations India Ltd trades at Rs 22.06, a change of 2.01 (10.02%) on the day. Prices are live and subject to change.

What is the market capitalisation of Syncom Formulations India Ltd? +

As of 28 September 2026, Syncom Formulations India Ltd has a market cap of about Rs 1885.64 crore. This figure is live and moves with the share price.

Is Syncom Formulations India Ltd profitable? +

In March 2026, Syncom Formulations India Ltd reported a profit after tax of Rs 76.44 crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Syncom Formulations India Ltd? +

: As of 28 September 2026, the PE (TTM) for Syncom Formulations India Ltd is 22.29 and the price-to-book ratio is 4.57. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Syncom Formulations India Ltd pay a dividend? +

As of 28 September 2026, the dividend yield for Syncom Formulations India Ltd is 0.5%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Syncom Formulations India Ltd? +

As of the latest disclosed pattern, promoters hold 50.57% of Syncom Formulations India Ltd. Public shareholding is 49.43%, including mutual funds at 0.00% and foreign institutional investors at 0.35%.

What were the latest annual financials of Syncom Formulations India Ltd? +

In March 2026, Syncom Formulations India Ltd reported net sales of Rs 489.17 crore, revenue growth of 5.20%, and earnings per share of Rs 0.81.